Towards Healthcare
Middle East and Africa Biotechnology Market to Boom USD 125.91 Bn by 2034

Middle East and Africa Biotechnology Market Advances and Trends

According to forecasts, the Middle East and Africa biotechnology market will grow from USD 46.53 billion in 2024 to USD 125.91 billion by 2034, with an expected CAGR of 10.80%. Rising food security concerns are estimated to drive the growth of the market. South Africa led the global market owing to its advanced research infrastructure in the region.

  • Insight Code: 6275
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

FAQ's

The Middle East and Africa Biotechnology market stands at USD 51.47 billion in 2025 and is expected to reach USD 125.91 billion by 2034, growing at a CAGR of 10.80% from 2024 to 2034.

South Africa is leading the Middle East and Africa Biotechnology Market share 25% due to the strong institutions for vaccine development, genomics, and agricultural biotechnology, fostering innovation and commercialization.

Key trends include the Hybrid & climate-resilient seeds, plant growth regulators, and adoption of inorganic growth strategies, among others.

Governments are implementing policies and funding programs to promote R&D, biotechnology parks, and local manufacturing

Federation of African Societies of Biochemistry and Molecular Biology (FASBMB), International Centre for Genetic Engineering and Biotechnology (ICGEB), Biopharma Middle East & Africa, clinicaltrials.gov, A3P Middle East, WHO, Association of Agricultural Research Institutions in the Near East and North Africa, JAMA, International Centre for Genetic Engineering and Biotechnology (ICGEB), GOV.UK